A cybersecurity software company with two segments — consumer and enterprise. Q1 FY27 revenue fell 21.4% YoY to ₹45 Cr, with consumer revenue down 39% and enterprise down 5.5%. Revenue is largely subscription-based, evidenced by deferred revenue of ₹52.3 Cr and an order book of ₹56 Cr as of Q1 FY27. Employee costs are the dominant expense at 70.1% of FY26 revenue, consistent with a software and services-led model. Receivables collection is improving, with overdues reduced from ₹151 Cr to ₹107 Cr. Harish Kumar GS took charge as CEO on June 18, 2026. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Consumer, Enterprise. Subscription-driven cybersecurity software business; labour-heavy, software/services-led model
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 342 | 278 | 292 | 280 | 261 |
| EBITDA (ex other income) | 107 | 2 | 18 | (7) | (29) |
| margin % | 31.3 | 0.7 | 6.0 | (2.4) | (11.3) |
| Owners' profit | 0 | 0 | 0 | 0 | 0 |
| EPS, as reported (₹) | 14.01 | 1.14 | 4.56 | 0.94 | (1.98) |
| ROE % · ROCE % | 13.3 · 17.3 | 1.5 · 1.9 | 5.5 · 6.0 | 1.1 · 0.3 | (2.5) · (4.7) |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | 127 | 31 | 18 | (22) | 15 |
| Capex | (6) | (4) | (8) | (14) | (15) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 73 | 71 | 65 | 57 | 84 | 72 | 49 | 45 |
| Profit before tax | 5 | (2) | (7) | (7) | 10 | 6 | (30) | (7) |
| Net profit | 4 | 0 | (3) | (6) | 8 | 7 | (20) | (5) |
| EPS (₹) | 0.77 | 0.02 | (0.60) | (1.00) | 1.43 | 1.19 | (3.58) | (0.94) |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 7 Sept 2026 · SVP Enterprise Sales resigns after less than a month on the job | management changes | medium | — | — |
| 7 Sept 2026 · Senior VP Enterprise Sales Samuel Sathyajith resigns from Quick Heal | management changes | medium | — | — |
| 3 Sept 2026 · Quick Heal allots 9,746 shares under ESOP Scheme 2021 | capital market events | low | — | — |
| 1 Sept 2026 · Quick Heal appoints Amit Chaudhary as VP - Product Management | management changes | medium | — | — |
| 27 Aug 2026 · Annual Report dispatch complete, 31st AGM on September 23, 2026 | compliance | minimal | — | — |
| 26 Aug 2026 · Quick Heal 31st AGM on Sept 23, 2026 via VC; FY26 Annual Report link shared | compliance | minimal | — | — |
| 26 Aug 2026 · Quick Heal 31st AGM on Sep 23, 2026; director re-appointments and FY26 results on agenda | board shareholder meetings | low | — | — |
| 21 Aug 2026 · AGM notice published in newspapers; 31st AGM on September 23, 2026 | compliance | minimal | — | — |
| 20 Aug 2026 · 31st Annual General Meeting set for September 23, 2026 | board shareholder meetings | low | — | — |
| 11 Aug 2026 · Quick Heal grants 1.02 lakh ESOP options to employees at Rs 76 each | capital market events | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
